biotech
Bio-AnalystSupplement research
person
arrow_backExplore/Chondroitin

Chondroitin

Bone, joint, and mobility

Human studies reported between-group improvement in BML scores.

Single-ingredient studies · Human studies · Includes patient groups · between-group comparison

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 12

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.

What has been studied?

Distinct human comparison papers: 2

Some studies tested several ingredients together. Those results cannot show this ingredient’s separate effect or establish synergy.

  • BML scores

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient · 12 months
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Biomarker
      • Between-group comparison
      • Timepoint: 12 months
      • Study comparison: chondroitin versus placebo through month 6; open-label thereafter
  • cartilage volume

    Research with unclear study subject or type
    • No clear difference in this measurement was found between the compared groups.
      Patient group · Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: unspecified
  • cartilage volume loss

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • pain during activity

    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Patient group · Combination study · 3–6 months
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Ingredient combination
      • Patient group
      • Primary outcome
      • Between-group comparison
      • Study subject not identified
      • Timepoint: 3–6 months
      • Study comparison: specific Structum chondroitin sulfate preparation versus placebo
Other measured outcomes (1)
  • TKRs

    • Comparison result:No clear difference from the comparison group was found.
      Patient group · Single ingredient · 4-year follow-up
      Measurement and study conditions
      • Controlled human study
      • Controlled trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: 4-year follow-up
      • Study comparison: post hoc long-term comparison of prior CS versus placebo assignment

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (5)
  • joint space narrowing · Distinct papers needing additional review: 1Direction unclear: 1
  • knee pain · Distinct papers needing additional review: 1Evidence criteria check: 1
  • pain intensity · Distinct papers needing additional review: 1Evidence criteria check: 1
  • perceptions of knee pain · Distinct papers needing additional review: 1Direction unclear: 1
  • visual analogue scale (VAS) score · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Bone, joint, and mobility

    Related papers 12 · human comparison papers 2

    View selected result
  • Skin, hair, and nails

    Related papers 3 · human comparison papers 1

    View results
    • Skin elasticity · Improvement reported · Some studies used more than one ingredient
    • skin dryness/scaling · Some studies used more than one ingredient

    More outcome groups: 1

  • Immune and respiratory health

    Related papers 2 · comparison findings need further review

    View results
    • UTI rate per patient-year · Interpretation held
  • Exercise performance

    Related papers 1 · comparison findings need further review

    View results
  • Glucose and metabolic health

    Related papers 1 · comparison findings need further review

    View results
  • Migraine and pain

    Related papers 1 · comparison findings need further review

    View results
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 51.5 evidence score includes 1 independent human studies and 0 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 70

Papers linked to this topic 12 · distinct papers 12 · papers with a confirmed human comparison 2 · papers needing additional review 9

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • BML scores: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • cartilage volume: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • cartilage volume loss: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • joint space narrowing: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • knee pain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • pain during activity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • pain intensity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • perceptions of knee pain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • TKRs: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • visual analogue scale (VAS) score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Bone, joint, and mobility

What the research found

TKRs

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

BML scores

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cartilage volume loss

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cartilage volume

No clear difference in this measurement was found between the compared groups.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

pain during activity

The study reported improvement in this measurement.

Meta-analysis · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

joint space narrowing

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

knee pain

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

pain intensity

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

perceptions of knee pain

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

visual analogue scale (VAS) score

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Skin, hair, and nails

What the research found

Skin elasticity

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

skin dryness/scaling

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

skin permeation

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Immune and respiratory health

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

UTI rate per patient-year

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Migraine and pain

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
0
Findings from individual and combined use, plus reviewed cautions
Key precautions
No combination cautions are available to show in the current data. This does not guarantee safety.
These findings were reported in studies. They do not predict an individual's experience.

Side effects and combination studies

No side-effect or combination findings are available to show from the collected papers. This does not establish safety.